Page last updated: 2024-08-25

bexarotene and EBV Infections

bexarotene has been researched along with EBV Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aqui, NA; Bloom, RD; Nasta, SD; Schuster, SJ; Tsai, DE; Vogl, DT; Wasik, MA	1

Other Studies

1 other study(ies) available for bexarotene and EBV Infections

Article	Year
Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid analog bexarotene. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:8 Topics: Anticarcinogenic Agents; Bexarotene; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Kidney Transplantation; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Postoperative Complications; Tetrahydronaphthalenes; Viral Load	2005

Article

Year

Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid analog bexarotene.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:8

Topics: Anticarcinogenic Agents; Bexarotene; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Kidney Transplantation; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Postoperative Complications; Tetrahydronaphthalenes; Viral Load

2005